References
- World Health Organization. (n.d.) Cancer Tomorrow. Retrieved December 22, 2019, from https://gco.iarc.fr/tomorrow/graphic-isotype?type=1&population=900&mode=population&sex=0&cancer=39&age_group=value&apc_male=0&apc_female=0.
- Hassan SM, Khalaf MM, Sadek SA, Abo-Youssef AM. Protective effects of apigenin and myricetin against cisplatin-induced nephrotoxicity in mice. Pharm Biol. 2017;55(1):766–74. doi:https://doi.org/10.1080/13880209.2016.1275704
- Khan TH, Ganaie MA, Alharthy KM, Madkhali H, Jan BL, Sheikh IA. Naringenin prevents doxorubicin-induced toxicity in kidney tissues by regulating the oxidative and inflammatory insult in Wistar rats. Arch Physiol Biochem. 2018;126(4):300–7. doi:https://doi.org/10.1080/13813455.2018.1529799
- Amaral RG, Albuquerque dos Santos S, Andrade LN, Severino P, Carvalho AA. Natural products as treatment against cancer: A historical and current vision. Clin Oncol. 2019;4:1562.
- Rahman HS. Natural products for cancer therapy. Dual Diagnosis. 2016;1(2):15. doi:https://doi.org/10.21767/2472-5048.100015
- Lichota A, Gwozdzinski K. Activity of natural compounds from plant and marine environment. IJMS. 2018;19(11):3533–8. doi:https://doi.org/10.3390/ijms19113533
- Mitra S, Dash R. Natural products for the management and prevention of breast cancer. Evid Based Complement Alternat Med. 2018;2018:8324696. doi:https://doi.org/10.1155/2018/8324696
- Huang H, Chen AY, Rojanasakul Y, Ye X, Rankin GO, Chen YC. Dietary compounds galangin and myricetin suppress ovarian cancer cell angiogenesis. J Funct Foods. 2015;15:464–75. doi:https://doi.org/10.1016/j.jff.2015.03.051
- Zhang S, Wang L, Liu H, Zhao G, Ming L. Enhancement of recombinant myricetin on the radiosensitivity of lung cancer A549 and H1299 cells. Diagn Pathol. 2014;9:68. doi:https://doi.org/10.1186/1746-1596-9-68
- Chen Y-Y, Chang Y-M, Wang K-Y, Chen P-N, Hseu Y-C, Chen K-M, Yeh KT, Chen CJ, Hsu L-S. Naringenin inhibited migration and invasion of glioblastoma cells through multiple mechanisms. Environ Toxicol. 2019;34(3):233–9. doi:https://doi.org/10.1002/tox.22677
- Patel PN, Yu X-M, Jaskula-Sztul R, Chen H. Hesperetin activates the Notch1 signaling cascade, causes apoptosis, and induces cellular differentiation in anaplastic thyroid cancer. Ann Surg Oncol. 2014;21(S4):497–504. doi:https://doi.org/10.1245/s10434-013-3459-7
- Semwal DK, Semwal RB, Combrinck S, Viljoen A. Myricetin: A dietary molecule with diverse biological activities. Nutrients. 2016;8(2):90. doi:https://doi.org/10.3390/nu8020090
- Afra H, Zangooei M, Meshkani R, Ghahremani M, Ilbeigi D, Khedri A, Shahmohamadnejad S, Khaghani S, Nourbakhsh M. Hesperetin is a potent bioactivator that activates SIRT1-AMPK signaling pathway in HepG2 cells. J Physiol Biochem. 2019;75(2):125–33. doi:https://doi.org/10.1007/s13105-019-00678-4
- Xu X, Lei T, Li W, Ou H. Enhanced cellular cholesterol efflux by naringenin is mediated through inhibiting endoplasmic reticulum stress - ATF6 activity in macrophages. Biochim Biophys Acta Mol Cell Biol Lipids. 2019;1864(10):1472–1482. doi:https://doi.org/10.1016/j.bbalip.2019.06.005
- Greten FR, Grivennikov SI. Inflammation and cancer: triggers, mechanisms, and consequences. Immunity. 2019;51(1):27–41. doi:https://doi.org/10.1016/j.immuni.2019.06.025
- Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. Oxidative stress, inflammation, and cancer: How are they linked?Free Radic Biol Med. 2010;49(11):1603–1616. doi:https://doi.org/10.1016/j.freeradbiomed.2010.09.006
- Lu H, Ouyang W, Huang C. Inflammation, a key event in cancer development. Mol Cancer Res. 2006;4(4):221–54. doi:https://doi.org/10.1158/1541-7786.MCR-05-0261
- Todoric J, Antonucci L, Karin M. Targeting Inflammation in Cancer Prevention and Therapy. Cancer Prev Res (Phila)). 2016; 9(12):895–905. doi:https://doi.org/10.1158/1940-6207.CAPR-16-0209
- Chelombitko MA. Role of reactive oxygen species in inflammation: a minireview. Moscow Univ Biolsci Bull. 2018;73(4):199–202. doi:https://doi.org/10.3103/S009639251804003X
- Kumari S, Badana AK, Murali Mohan G, Shailender G, Malla RR. Reactive oxygen species: A key constituent in cancer survival. Biomark Insights. 2018;13: 1–9. doi:https://doi.org/10.1177/1177271918755391
- Reczek CR, Chandel NS. The two faces of reactive oxygen species in cancer. Annu Rev Cancer Biol. 2017;1(1):79–98. doi:https://doi.org/10.1146/annurev-cancerbio-041916-065808
- Yang Z, Qi Y, Lai N, Zhang J, Chen Z, Liu M, Zhang W, Luo R, Kang S. The role of cellular reactive oxygen species in cancer chemotherapy. J Exp Clin Cancer Res. 2018;37(1):1–10. doi:https://doi.org/10.1186/s13046-017-0664-4
- Jayakumar JK, Nirmala P, Praveen Kumar BA, Kumar AP. Evaluation of protective effect of myricetin, a bioflavonoid in dimethyl benzanthracene-induced breast cancer in female Wistar rats. South Asian J Cancer. 2014;3(2):107–11. doi:https://doi.org/10.4103/2278-330X.130443
- Dobson JM, Hohenhaus AE, Peaston AE. Cancer chemotherapy. In: Maddison J, Page S, Church D, editors. Small animal clinical pharmacology. Amsterdam: Elsevier; 2008. p. 330–66. https://doi.org/10.1016/B978-070202858-8.50017-8
- Tavsan Z, Kayali HA. Flavonoids showed anticancer effects on the ovarian cancer cells: Involvement of reactive oxygen species, apoptosis, cell cycle and invasion. Biomed Pharmacother. 2019;116:109004. doi:https://doi.org/10.1016/j.biopha.2019.109004
- Yang C, Lim W, Bazer FW, Song G. Myricetin suppresses invasion and promotes cell death in human placental choriocarcinoma cells through induction of oxidative stress. Cancer Lett. 2017;399:10–19. doi:https://doi.org/10.1016/j.canlet.2017.04.014
- Knickle A, Fernando W, Greenshields AL, Rupasinghe HPV, Hoskin DW. Myricetin-induced apoptosis of triple-negative breast cancer cells is mediated by the iron-dependent generation of reactive oxygen species from hydrogen peroxide. Food Chem Toxicol. 2018;118:154–67. doi:https://doi.org/10.1016/j.fct.2018.05.005
- Bodduluru LN, Kasala ER, Barua CC, Karnam KC, Dahiya V, Ellutla M. Antiproliferative and antioxidant potential of hesperetin against benzo(a)pyrene-induced lung carcinogenesis in Swiss albino mice. Chem Biol Interact. 2015;242:345–52. doi:https://doi.org/10.1016/j.cbi.2015.10.020
- Zhang M-J, Su H, Yan J-Y, Li N, Song Z-Y, Wang H-J, Huo L-G, Wang F, Ji W-S, Qu X-J, et al. Chemopreventive effect of Myricetin, a natural occurring compound, on colonic chronic inflammation and inflammation-driven tumorigenesis in mice. Biomed Pharmacother. 2018;97:1131–1137. doi:https://doi.org/10.1016/j.biopha.2017.11.018
- Liang J, Halipu Y, Hu F, Yakeya B, Chen W, Zhang H, Kang X. Naringenin protects keratinocytes from oxidative stress injury via inhibition of the NOD2-mediated NF-κB pathway in pemphigus vulgaris. Biomed Pharmacother. 2017;92:796–801. doi:https://doi.org/10.1016/j.biopha.2017.05.112
- Lian G, Wang Q, Tang P, Zhou S, Huang X, Lan H. Combination of asiatic acid and naringenin modulates NK cell anti-cancer immunity by rebalancing Smad3/Smad7 Signaling. Mol Ther. 2018;26(9):2255–66. doi:https://doi.org/10.1016/j.ymthe.2018.06.016
- Jo SH, Kim ME, Cho JH, Lee Y, Lee J, Park Y-D, Lee JS. Hesperetin inhibits neuroinflammation on microglia by suppressing inflammatory cytokines and MAPK pathways. Arch Pharm Res. 2019;42(8):695–703. doi:https://doi.org/10.1007/s12272-019-01174-5
- Park S, Lim W, Bazer FW, Song G. Naringenin suppresses growth of human placental choriocarcinoma via reactive oxygen species-mediated P38 and JNK MAPK pathways. Phytomedicine. 2017;50:238–46. doi:https://doi.org/10.1016/j.phymed.2017.08.026
- Park HJ, Choi YJ, Lee JH, Nam MJ. Naringenin causes ASK1-induced apoptosis via reactive oxygen species in human pancreatic cancer cells. Food Chem Toxicol. 2017;99:1–8. doi:https://doi.org/10.1016/j.fct.2016.11.008
- Zhang J, Wu D, VikashSong J, Wang J, Yi J, Dong W. Hesperetin induces the apoptosis of gastric cancer cells via activating mitochondrial pathway by increasing reactive oxygen species. Dig Dis Sci. 2015;60(10):2985–2995. doi:https://doi.org/10.1007/s10620-015-3696-7
- Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;19(420):860–7.
- Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140(6):883–99. doi:https://doi.org/10.1016/j.cell.2010.01.025
- Cho BO, Yin HH, Park SH, Byun EB, Ha HY, Jang SI. Anti-inflammatory activity of myricetin from Diospyros lotus through suppression of NF-κB and STAT1 activation and Nrf2-mediated HO-1 induction in lipopolysaccharide-stimulated RAW264.7 macrophages. Bioscience. Biosci Biotechnol Biochem. 2016;80(8):1520–30. doi:https://doi.org/10.1080/09168451.2016.1171697
- Hou W, Hu S, Su Z, Wang Q, Meng G, Guo T, Zhang J, Gao P. Myricetin attenuates LPS-induced inflammation in RAW 264.7 macrophages and mouse models. Future Med Chem. 2018;10(19):2253–64. doi:https://doi.org/10.4155/fmc-2018-0172
- Pan X, Chen T, Zhang Z, Chen X, Chen C, Chen L, Wang X, Ying X. Activation of Nrf2/HO-1 signal with myricetin for attenuating ECM degradation in human chondrocytes and ameliorating the murine osteoarthritis. Int Immunopharmacol. 2019;75:1–13. doi:https://doi.org/10.1016/j.intimp.2019.105742
- Ye J, Guan M, Lu Y, Zhang D, Li C, Li Y, Zhou C. Protective effects of hesperetin on lipopolysaccharide-induced acute lung injury by targeting MD2. Eur J Pharmacol. 2019;852:151–158. doi:https://doi.org/10.1016/j.ejphar.2019.02.042
- Furler R, Nixon D, Brantner C, Popratiloff A, Uittenbogaart C. TGF-β sustains tumor progression through biochemical and mechanical signal transduction. Cancers. 2018;10(6):199. doi:https://doi.org/10.3390/cancers10060199
- Hernández-Aquino E, Quezada-Ramírez MA, Silva-Olivares A, Casas-Grajales S, Ramos-Tovar E, Flores-Beltrán RE, Segovia J, Shibavama M, Muriel P. Naringenin attenuates the progression of liver fibrosis via inactivation of hepatic stellate cells and profibrogenic pathways. Eur J Pharmacol. 2019;865:172730. doi:https://doi.org/10.1016/j.ejphar.2019.172730
- Cichy J, Kulig P, Puré E. Regulation of the release and function of tumor cell-derived soluble CD44. Biochim Biophys Acta. 2005;1745(1):59–64. doi:https://doi.org/10.1016/j.bbamcr.2005.02.006
- Zhang F, Dong W, Zeng W, Zhang L, Zhang C, Qiu Y, Wang L, Yin X, Zhang C, Liang W. Naringenin prevents TGF-β1 secretion from breast cancer and suppresses pulmonary metastasis by inhibiting PKC activation. Breast Cancer Res. 2016;18(1):38. doi:https://doi.org/10.1186/s13058-016-0698-0
- Bodduluru LN, Kasala ER, Madhana RM, Barua CC, Hussain MI, Haloi P, Borah P. Naringenin ameliorates inflammation and cell proliferation in benzo(a)pyrene induced pulmonary carcinogenesis by modulating CYP1A1, NFκB and PCNA expression. Int Immunopharmacol. 2016;30:102–10. doi:https://doi.org/10.1016/j.intimp.2015.11.036
- Jin L, Zeng W, Zhang F, Zhang C, Liang W. Naringenin ameliorates acute inflammation by regulating intracellular cytokine degradation. J Immunol. 2017;199(10):3466–77. doi:https://doi.org/10.4049/jimmunol.1602016
- Ruiz-Miyazawa K, Borghi S, Pinho-Ribeiro F, Staurengo-Ferrari L, Fattori V, Fernandes G, Casella A, Alves-Filho J, Cunha T, Cunha F, et al. The citrus flavanone naringenin reduces gout-induced joint pain and inflammation in mice by inhibiting the activation of NFκB and macrophage release of IL-1β. J Funct Foods. 2018;48:106–116. doi:https://doi.org/10.1016/j.jff.2018.06.025
- Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation. Cell. 2011;144(5):646–74. doi:https://doi.org/10.1016/j.cell.2011.02.013
- Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2014;15(3):178–96. doi:https://doi.org/10.1038/nrm3758
- Videira M, Reis RL, Brito MA. Deconstructing breast cancer cell biology and the mechanisms of multidrug resistance. Biochim Biophys Acta. 2014;1846(2):312–325. doi:https://doi.org/10.1016/j.bbcan.2014.07.011
- Ye C, Zhang C, Huang H, Yang B, Xiao G, Kong D, Tian Q, Song Q, Song Y, Tan H, et al. The natural compound myricetin effectively represses the malignant progression of prostate cancer by inhibiting PIM1 and disrupting the PIM1/CXCR4 interaction. Cell Physiol Biochem. 2018;48(3):1230–1244. doi:https://doi.org/10.1159/000492009
- Zang W, Wang T, Wang Y, Li M, Xuan X, Ma Y, Du Y, Liu K, Dong Z, Zhao G. Myricetin exerts anti-proliferative, anti-invasive, and pro-apoptotic effects on esophageal carcinoma EC9706 and KYSE30 cells via RSK2. Tumour Biol. 2014;35(12):12583–12592. doi:https://doi.org/10.1007/s13277-014-2579-4
- Han KY, Chen P-N, Hong M-C, Hseu Y-C, Chen K-M, Hsu L-S, Chen W-J. Naringenin attenuated prostate cancer invasion via reversal of epithelial-to-mesenchymal transition and inhibited uPA activity. Anticancer Res. 2018;38(12):6753–8. doi:https://doi.org/10.21873/anticanres.13045
- Iyer SC, Gopal A, Halagowder D. Myricetin induces apoptosis by inhibiting P21 activated kinase 1 (PAK1) signaling cascade in hepatocellular carcinoma. Mol Cell Biochem. 2015;407(1–2):223–37. doi:https://doi.org/10.1007/s11010-015-2471-6
- Elango R, Athinarayanan J, Subbarayan VP, Lei DKY, Alshatwi AA. Hesperetin induces an apoptosis-triggered extrinsic pathway and a p53- independent pathway in human lung cancer H522 cells. J Asian Nat Prod Res. 2018;20(6):559–69. doi:https://doi.org/10.1080/10286020.2017.1327949
- Wang R, Wang J, Dong T, Shen J, Gao X, Zhou J. Naringenin has a chemoprotective effect in MDA‑MB‑231 breast cancer cells via inhibition of caspase‑3 and ‑9 activities. Oncol Lett. 2018;17(1):1217–1222. doi:https://doi.org/10.3892/ol.2018.9704
- Jiao D, Zhang XD. Myricetin suppresses p21-activated kinase 1 in human breast cancer MCF-7 cells through downstream signaling of the β-catenin pathway. Oncol Rep. 2016;36(1):342–8. doi:https://doi.org/10.3892/or.2016.4777
- Chandrika BB, Steephan M, Kumar TRS, Sabu A, Haridas M. Hesperetin and Naringenin sensitize HER2 positive cancer cells to death by serving as HER2 Tyrosine Kinase inhibitors. Life Sci. 2016;160:47–56. doi:https://doi.org/10.1016/j.lfs.2016.07.007
- Xu Z, Huang B, Liu J, Wu X, Luo N, Wang X, Zheng X, Pan X. Combinatorial anti-proliferative effects of tamoxifen and naringenin: The role of four estrogen receptor subtypes. Toxicology. 2018;410:231–246. doi:https://doi.org/10.1016/j.tox.2018.08.013
- Wu D, Zhang J, Wang J, Li J, Liao F, Dong W. Hesperetin induces apoptosis of esophageal cancer cells via mitochondrial pathway mediated by the increased intracellular reactive oxygen species. Tumor Biol. 2016;37(3):3451–3459. doi:https://doi.org/10.1007/s13277-015-4176-6
- Zhang J, Song J, Wu D, Wang J, Dong W. Hesperetin induces the apoptosis of hepatocellular carcinoma cells via mitochondrial pathway mediated by the increased intracellular reactive oxygen species. Med Oncol. 2015;32(4):101. doi:https://doi.org/10.1007/s12032-015-0516-z
- Shih Y-W, Wu P-F, Lee Y-C, Shi M-D, Chiang T-A. Myricetin suppresses invasion and migration of human lung adenocarcinoma A549 cells: Possible mediation by blocking the ERK signaling pathway. J Agric Food Chem. 2009;57(9):3490–3499. doi:https://doi.org/10.1021/jf900124r
- Wang Y, Liu S, Dong W, Qu X, Huang C, Yan T, Du J. Combination of hesperetin and platinum enhances anticancer effect on lung adenocarcinoma. Biomed Pharmacother. 2019;113:108779. doi:https://doi.org/10.1016/j.biopha.2019.108779
- Parashar P, Tripathi C, Arya M, Kanoujia J, Singh M, Yadav A, Amit K, Guleria A, Saraf S. Biotinylated naringenin intensified anticancer effect of gefitinib in urethane-induced lung cancer in rats: favourable modulation of apoptotic regulators and serum metabolomics. Artificial Cells, Nanomedicine and Biotechnology. 2018;46(3):598–610. https://doi.org/10.1080/21691401.2018.1505738
- Das A, Monteiro M, Barai A, Kumar S, Sen S. MMP proteolytic activity regulates cancer invasiveness by modulating integrins. Sci Rep. 2017;7(1):14219. doi:https://doi.org/10.1038/s41598-017-14340-w
- Huang H. Matrix metalloproteinase-9 (MMP-9) as a cancer biomarker and MMP-9 biosensors: Recent advances. Sensors. 2018;18(10):1–19. doi:https://doi.org/10.3390/s18103249
- Webb A, Gao B, Goldsmith Z, Irvine A, Saleh N, Lee R, Lendermon J, Bheemreddy R, Zhang Q, Brennan R, et al. Inhibition of MMP-2 and MMP-9 decreases cellular migration, and angiogenesis in in vitro models of retinoblastoma. BMC Cancer. 2017;17(1):434. doi:https://doi.org/10.1186/s12885-017-3418-y
- Ci Y, Zhang Y, Liu Y, Lu S, Cao J, Li H, Zhang J, Huang Z, Zhu X, Gao J, et al. Myricetin suppresses breast cancer metastasis through down-regulating the activity of matrix metalloproteinase (MMP)-2/9. Phytother Res. 2018;32(7):1373–81. doi:https://doi.org/10.1002/ptr.6071
- Chang H-L, Chang Y-M, Lai S-C, Chen K-M, Wang K-C, Chiu T-T, Chang F-H, Hsu L-S. Naringenin inhibits migration of lung cancer cells via the inhibition of matrix metalloproteinases-2 and -9. Exp Ther Med. 2017;13(2):739–44. doi:https://doi.org/10.3892/etm.2016.3994
- Eanes L, Patel YM. Inhibition of the MAPK pathway alone is insufficient to account for all of the cytotoxic effects of naringenin in MCF-7 breast cancer cells. Biochim Open. 2016;3:64–71. doi:https://doi.org/10.1016/j.biopen.2016.09.004
- Yen H-R, Liu C-J, Yeh C-C. Naringenin suppresses TPA-induced tumor invasion by suppressing multiple signal transduction pathways in human hepatocellular carcinoma cells. Chem Biol Interact. 2015;235:1–9. doi:https://doi.org/10.1016/j.cbi.2015.04.003
- Kapoor R, Sirohi VK, Gupta K, Dwivedi A. Naringenin ameliorates progression of endometriosis by modulating Nrf2/Keap1/HO1 axis and inducing apoptosis in rats. J Nutr Biochem. 2019;70:215–26. doi:https://doi.org/10.1016/j.jnutbio.2019.05.003
- Sheokand S, Navik U, Bansal AK. Nanocrystalline solid dispersions (NSD) of hesperetin (HRN) for prevention of 7, 12-dimethylbenz[a]anthracene (DMBA)-induced breast cancer in Sprague-Dawley (SD) rats. Eur J Pharm Sci. 2019;128:240–249. doi:https://doi.org/10.1016/j.ejps.2018.12.006
- Aranganathan S, Nalini N. Antiproliferative efficacy of hesperetin (citrus flavanoid) in 1,2-dimethylhydrazine-induced colon cancer. Phytother Res. 2013;27(7):999–1005. doi:https://doi.org/10.1002/ptr.4826
- Pereira L, Horta S, Mateus R, Videira MA. Implications of Akt2/Twist crosstalk on breast cancer metastatic outcome. Drug Discov Today. 2015;20(9):1152–1158. doi:https://doi.org/10.1016/j.drudis.2015.06.010
- Revathidevi S, Munirajan AK. Akt in cancer: Mediator and more. Semin Cancer Biol. 2019;59:80–91. doi:https://doi.org/10.1016/j.semcancer.2019.06.002
- Kim W, Jung H, Youn H, Ju Y, Moon K, Youn B. Myricetin inhibits Akt survival signaling and induces bad-mediated apoptosis in a low dose ultraviolet (UV)-B-irradiated HaCaT human immortalized keratinocytes. 2010;J Radiat Res. (3)51:285–96. doi:https://doi.org/10.1269/jrr.09141
- Yao A, Shen Y, Zhang Z, Zou Z, Wang A, Chen S, Zhang H, Chen F, Zhao J, Chen Z, et al. Sulforaphane and myricetin act synergistically to induce apoptosis in 3T3‑L1 adipocytes. Mol Med Rep. 2017;17(2):2945–2951. doi:https://doi.org/10.3892/mmr.2017.8235
- Lee DH, Lee CS. Flavonoid myricetin inhibits TNF-α-stimulated production of inflammatory mediators by suppressing the Akt, mTOR and NF-κB pathways in human keratinocytes. Eur J Pharmacol. 2016;784:164–72. doi:https://doi.org/10.1016/j.ejphar.2016.05.025
- Li Y, Cui S, Sun S, Shi W, Song Z, Wang S, Yu X, Gao Z, Qu X. Chemoprevention of intestinal tumorigenesis by the natural dietary flavonoid myricetin in APCMin/+ mice. Oncotarget. 2016;7(37):60446–60. doi:https://doi.org/10.18632/oncotarget.11108
- Bao L, Liu F, Guo HB, Li Y, Tan BB, Zhang WX, Peng YH. Naringenin inhibits proliferation, migration, and invasion as well as induces apoptosis of gastric cancer SGC7901 cell line by downregulation of AKT pathway. Tumour Biol. 2016;37(8):11365–74. doi:https://doi.org/10.1007/s13277-016-5013-2
- Zhao M, Li C, Shen F, Wang M, Jia N, Wang C. Naringenin ameliorates LPS-induced acute lung injury through its anti-oxidative and anti-inflammatory activity and by inhibition of the PI3K/AKT pathway. Exp Ther Med. 2017;14(3):2228–2234. doi:https://doi.org/10.3892/etm.2017.4772
- Feng J, Luo J, Deng L, Zhong Y, Wen X, Cai Y, Li J. Naringenin-induced HO-1 ameliorates high glucose or free fatty acids-associated apoptosis via PI3K and JNK/Nrf2 pathways in human umbilical vein endothelial cells. Int Immunopharmacol. 2019;75:105769. doi:https://doi.org/10.1016/j.intimp.2019.105769
- Lim W, Park S, Bazer FW, Song G. Naringenin-induced apoptotic cell death in prostate cancer cells is mediated via the PI3K/AKT and MAPK signaling pathways. J Cell Biochem. 2017;118(5):1118–31. doi:https://doi.org/10.1002/jcb.25729
- Lim W, Song G. Naringenin-induced migration of embrynoic trophectoderm cells is mediated via PI3K/AKT and ERK1/2 MAPK signaling cascades. Mol Cell Endocrinol. 2016;428:28–37. doi:https://doi.org/10.1016/j.mce.2016.03.018
- Govindammal M, Prasath M, Kamaraj S, Sathya B. Invivo, molecular docking, spectroscopy studies of (S)-2,3-Dihydro-5,7-dihydroxy-2(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one: A potential uptake PI3/AKT inhibitor. Biocatal Agric Biotechnol. 2019;18:101086. doi:https://doi.org/10.1016/j.bcab.2019.101086
- Kim GD. Hesperetin inhibits vascular formation by suppressing of the PI3K/AKT, ERK, and p38 MAPK signaling pathways. Prev Nutr Food Sci. 2014;19(4):299–306. doi:https://doi.org/10.3746/pnf.2014.19.4.299
- Shirzad M, Heidarian E, Beshkar P, Gholami-Arjenaki M. 2017; Biological effects of hesperetin on interleukin-6/phosphorylated signal transducer and activator of transcription 3 pathway signaling in prostate cancer PC3 cells. Pharmacogn Res. 9(2):188–194. https://doi.org/10.4103/0974-8490.204655
- Vauzour D, Corsini S, Müller M, Spencer JPE. Inhibition of PP2A by hesperetin may contribute to Akt and ERK1/2 activation status in cortical neurons. Arch Biochem Biophys. 2018;650:14–21. doi:https://doi.org/10.1016/j.abb.2018.04.020
- Yang Y, Wolfram J, Boom K, Fang X, Shen H, Ferrari M. Hesperetin impairs glucose uptake and inhibits proliferation of breast cancer cells. Cell Biochem Funct. 2013;31(5):374–379. doi:https://doi.org/10.1002/cbf.2905
- Bawazeer NA, Choudhry H, Zamzami MA, Abdulaal WH, Middleton B, Moselhy SS. Role of hesperetin in LDL-receptor expression in hepatoma HepG2 cells. BMC Complement Altern Med. 2016;16(1):182. doi:https://doi.org/10.1186/s12906-016-1165-2
- Dhuriya YK, Sharma D, Naik AA. Cellular demolition: Proteins as molecular players of programmed cell death. Int J Biol Macromol. 2019;138:492–503. doi:https://doi.org/10.1016/j.ijbiomac.2019.07.113
- Grilo AL, Mantalaris A. Apoptosis: A mammalian cell bioprocessing perspective. Biotechnol Adv. 2019;37(3):459–75. doi:https://doi.org/10.1016/j.biotechadv.2019.02.012
- Mansoori B, Mohammadi A, Davudian S, Shirjang S, Baradaran B. The different mechanisms of cancer drug resistance: A brief review. Adv Pharm Bull. 2017;7(3):339–48. doi:https://doi.org/10.15171/apb.2017.041
- Ha TK, Jung I, Kim ME, Bae SK, Lee JS. Anti-cancer activity of myricetin against human papillary thyroid cancer cells involves mitochondrial dysfunction-mediated apoptosis. Biomed Pharmacother. 2017;91:378–84. doi:https://doi.org/10.1016/j.biopha.2017.04.100
- Huang H, Chen AY, Ye X, Li B, Rojanasakul Y, Rankin GO, Chen YC. Myricetin inhibits proliferation of cisplatin-resistant cancer cells through a p53-dependent apoptotic pathway. Int J Oncol. 2015;47(4):1494–502. doi:https://doi.org/10.3892/ijo.2015.3133
- Xu Y, Xie Q, Wu S, Yi D, Yu Y, Liu S, Li S, Li Z. Myricetin induces apoptosis via endoplasmic reticulum stress and DNA double-strand breaks in human ovarian cancer cells. Mol Med Rep. 2016;13(3):2094–2100. doi:https://doi.org/10.3892/mmr.2016.4763
- Tan YQ, Chiu-Leung LC, Lin S, Leung LK. The citrus flavonone hesperetin attenuates the nuclear translocation of aryl hydrocarbon receptor. Comp Biochem Physiol C Toxicol Pharmacol. 2018;210:57–64. doi:https://doi.org/10.1016/j.cbpc.2018.05.007
- Tan G, Uson-Lopez RA, Rahman MM, Hosokawa T, Saito T, Kurasaki M. Myricetin enhances on apoptosis induced by serum deprivation in PC12 cells mediated by mitochondrial signaling pathway. Environ Toxicol Pharmacol. 2018;57:175–180. doi:https://doi.org/10.1016/j.etap.2017.12.016
- Zhang Y, Chen S, Wei C, Rankin GO, Ye X, Chen YC. Flavonoids from Chinese bayberry leaves induced apoptosis and G1 cell cycle arrest via Erk pathway in ovarian cancer cells. Eur J Med Chem. 2018;147:218–226. doi:https://doi.org/10.1016/j.ejmech.2018.01.084
- Palit S, Kar S, Sharma G, Das PK. Hesperetin induces apoptosis in breast carcinoma by triggering accumulation of ROS and activation of ASK1/JNK pathway. J Cell Physiol. 2015;230(8):1729–39. doi:https://doi.org/10.1002/jcp.24818
- Su C, Haskins A, Omata C, Aizawa Y, Kato T. PARP inhibition by flavonoids induced selective cell killing to BRCA2-deficient cells. Pharmaceuticals. 2017;10(4):80. doi:https://doi.org/10.3390/ph10040080
- Nasr Bouzaiene N, Chaabane F, Sassi A, Chekir-Ghedira L, Ghedira K. Effect of apigenin-7-glucoside, genkwanin and naringenin on tyrosinase activity and melanin synthesis in B16F10 melanoma cells. Life Sci. 2016;144:80–5. doi:https://doi.org/10.1016/j.lfs.2015.11.030
- Icard P, Fournel L, Wu Z, Alifano M, Lincet H. Interconnection between metabolism and cell cycle in cancer. Trends Biochem Sci. 2019;44(6):490–501. doi:https://doi.org/10.1016/j.tibs.2018.12.007
- Adan A, Baran Y. The pleiotropic effects of fisetin and hesperetin on human acute promyelocytic leukemia cells are mediated through apoptosis, cell cycle arrest, and alterations in signaling networks. Tumour Biol. 2015;36(11):8973–84. doi:https://doi.org/10.1007/s13277-015-3597-6
- Adan A, Baran Y. Fisetin and hesperetin induced apoptosis and cell cycle arrest in chronic myeloid leukemia cells accompanied by modulation of cellular signaling. Tumour Biol. 2016;37(5):5781–95. doi:https://doi.org/10.1007/s13277-015-4118-3
- Li Q, Miao Z, Wang R, Yang J, Zhang D. Hesperetin induces apoptosis in human glioblastoma cells via p38 MAPK activation. Nutr Cancer 2019;72(3):538–45. doi:https://doi.org/10.1080/01635581.2019.1638424
- Smina TP, Mohan A, Ayyappa KA, Sethuraman S, Krishnan UM. 2015; Hesperetin exerts apoptotic effect on A431 skin carcinoma cells by regulating mitogen activated protein kinases and cyclins. Cell Mol Biol (Noisy-le-rand). 61(6):92–99. https://doi.org/10.14715/cmb/2015.61.6.12
- Coutinho L, Oliveira H, Pacheco AR, Almeida L, Pimentel F, Santos C, Ferreira de Oliveira JMP. Hesperetin-etoposide combinations induce cytotoxicity in U2OS cells: Implications on therapeutic developments for osteosarcoma. DNA Repair (Amst)). 2017;50:36–42. doi:https://doi.org/10.1016/j.dnarep.2016.12.006
- Babukumar S, Vinothkumar V, Ramachandhiran D. Modulating effect of hesperetin on the molecular expression pattern of apoptotic and cell proliferative markers in 7,12-dimethylbenz(a)anthracene-induced oral carcinogenesis. Arch Physiol Biochem. 2019;126(5):1–10. doi:https://doi.org/10.1080/13813455.2018.1555600
- Babukumar S, Vinothkumar V, Velu P, Ramachandhiran D, Ramados Nirmal M. Molecular effects of hesperetin, a citrus flavanone on7,12-dimethylbenz(a)anthracene induced buccal pouch squamous cell carcinoma in golden Syrian hamsters. Arch Physiol Biochem. 2017;123(4):265–78. doi:https://doi.org/10.1080/13813455.2017.1317815
- Zhao Z, Jin G, Ge Y, Guo Z. Naringenin inhibits migration of breast cancer cells via inflammatory and apoptosis cell signaling pathways. Inflammopharmacol. 2019;27(5):1021–1036. doi:https://doi.org/10.1007/s10787-018-00556-3
- Liu M, Xu X, Zhao J, Tang Y. Naringenin inhibits transforming growth factor-β1-induced cardiac fibroblast proliferation and collagen synthesis via G0/G1 arrest. Exp Ther Med. 2017;14(5):4425–30. doi:https://doi.org/10.3892/etm.2017.5103
- Katayama K, Noguchi K, Sugimoto Y. Regulations of P-glycoprotein/ABCB1/MDR1 in human cancer cells. New J Sci. 2014;2014:1–11. doi:https://doi.org/10.1155/2014/476974
- Hao T, Ling Y, Wu M, Shen Y, Gao Y, Liang S, Gao Y, Qian S. Enhanced oral bioavailability of docetaxel in rats combined with myricetin: In situ and in vivo evidences. Eur J Pharm Sci. 2017;101:71–9. doi:https://doi.org/10.1016/j.ejps.2017.02.009
- Wei Y, Zhou S, Hao T, Zhang J, Gao Y, Qian S. Further enhanced dissolution and oral bioavailability of docetaxel by coamorphization with a natural P-gp inhibitor myricetin. Eur J Pharm Sci. 2019;129:21–30. doi:https://doi.org/10.1016/j.ejps.2018.12.016
- Zheng A, Chen Y, Zhao L, Feng J. Myricetin induces apoptosis and enhances chemosensitivity in ovarian cancer cells. Oncol Lett. 2017;13(6):4974–4978. doi:https://doi.org/10.3892/ol.2017.6031
- Larigot L, Juricek L, Dairou J, Coumoul X. AhR signaling pathways and regulatory functions. Biochim Open. 2018;7:1–9. doi:https://doi.org/10.1016/j.biopen.2018.05.001
- Sun H, Wang X, Zhou X, Lu D, Ma Z, Wu B. Multidrug resistance-associated protein 4 (MRP4/ABCC4) controls efflux transport of hesperetin sulfates in sulfotransferase 1A3-overexpressing human embryonic kidney 293 cells. Drug Metab Dispos. 2015;43(10):1430–1440. doi:https://doi.org/10.1124/dmd.115.065953
- Fan X, Bai J, Zhao S, Hu M, Sun Y, Wang B, Ji M, Jin J, Wang X, Hu J, et al. Evaluation of inhibitory effects of flavonoids on breast cancer resistance protein (BCRP): From library screening to biological evaluation to structure-activity relationship. Toxicol in Vitro. 2019;61:104642. doi:https://doi.org/10.1016/j.tiv.2019.104642
- Ferreira RJ, Gajdács M, Kincses A, Spengler G, dos Santos DJVA, Ferreira MJU. Nitrogen-containing naringenin derivatives for reversing multidrug resistance in cancer. Bioorg Med Chem. 2020;28(23):115798. doi:https://doi.org/10.1016/j.bmc.2020.115798
- Ravisankar S, Agah S, Kim H, Talcott S, Wu C, Awika J. Combined cereal and pulse flavonoids show enhanced bioavailability by downregulating phase II metabolism and ABC membrane transporter function in Caco-2 model. Food Chem. 2019;279:88–97. doi:https://doi.org/10.1016/j.foodchem.2018.12.006
- Stein A, Schmoll H-J. Which side effect related to chemotherapy should be described to the patients before treatment? In: Valentini V, Schmoll H-J, van de Velde CJH, editors. Multidisciplinary management of rectal cancer. Cham: Springer International Publishing; 2018. p. 349–54. doi:https://doi.org/10.1007/978-3-319-43217-5_44
- Zhang H, Zhong X, Zhang X, Shang D, Zhou YI, Zhang C. Enhanced anticancer effect of ABT-737 in combination with naringenin on gastric cancer cells. Exp Ther Med. 2016;11(2):669–673. doi:https://doi.org/10.3892/etm.2015.2912
- Pateliya B, Burade V, Goswami S. Combining naringenin and metformin with doxorubicin enhances anticancer activity against triple-negative breast cancer in vitro and in vivo. Eur J Pharmacol. 2021;891:173725. doi:https://doi.org/10.1016/j.ejphar.2020.173725
- Sak K, Lust H, Kase M, Saar M, Jaal J. Suppression of taxanes cytotoxicity by citrus flavonoid hesperetin in PPC-1 human prostate cancer cells. Anticancer Res. 2018;38(11):6209–6215. doi:https://doi.org/10.21873/anticanres.12975
- Yi J-L, Shi S, Shen Y-L, Wang L, Chen H-Y, Zhu J, Ding Y. Myricetin and methyl eugenol combination enhances the anticancer activity, cell cycle arrest and apoptosis induction of cis-platin against HeLa cervical cancer cell lines. Int J Clin Exp Pathol. 2015;8(2):1116–1127.
- Chen X, Wei W, Li Y, Huang J, Ci X. Hesperetin relieves cisplatin-induced acute kidney injury by mitigating oxidative stress, inflammation and apoptosis. Chem Biol Interact. 2019;308:269–78. doi:https://doi.org/10.1016/j.cbi.2019.05.040
- Chen Y-J, Kong L, Tang Z-Z, Zhang Y-M, Liu Y, Wang T-Y, Liu Y-W. Hesperetin ameliorates diabetic nephropathy in rats by activating Nrf2/ARE/glyoxalase 1 pathway. Biomed Pharmacother. 2019;111:1166–75. doi:https://doi.org/10.1016/j.biopha.2019.01.030
- Kumar M, Dahiya V, Kasala ER, Bodduluru LN, Lahkar M. The renoprotective activity of hesperetin in cisplatin induced nephrotoxicity in rats: Molecular and biochemical evidence. Biomed Pharmacother. 2017;89:1207–15. doi:https://doi.org/10.1016/j.biopha.2017.03.008
- Zhang C, Zeng W, Yao Y, Xu B, Wei X, Wang L, Yin X, Barman A, Zhang F, Zhang C, et al. Naringenin ameliorates radiation-induced lung injury by lowering IL-1β level. J Pharmacol Exp Ther. 2018;366(2):341–348. doi:https://doi.org/10.1124/jpet.118.248807
- Yu Y, Kong R, Cao H, Yin Z, Liu J, Nan X, Phan A, Ding T, Zhao H, Wong S. Two birds, one stone: hesperetin alleviates chemotherapy-induced diarrhea and potentiates tumor inhibition. Oncotarget. 2018;9(46):27958–27973. doi:https://doi.org/10.18632/oncotarget.24563